What's Happening?
Pulse Biosciences, Inc., a bioelectric medicine company, announced its participation in the 25th Annual Needham Virtual Healthcare Conference. The company will present its proprietary nPulse technology, which delivers nanosecond pulses of electrical energy
for non-thermal cell clearance. Pulse Biosciences is developing this technology for atrial fibrillation treatment and surgical soft tissue ablation. The presentation will be available via webcast on the company's investor website.
Why It's Important?
Pulse Biosciences' participation in the conference highlights its innovative approach to bioelectric medicine, which has the potential to improve patient outcomes in various medical fields. The company's nPulse technology represents a significant advancement in non-invasive treatment options, offering benefits for both patients and healthcare providers. The conference provides an opportunity for Pulse Biosciences to showcase its technology to investors and industry stakeholders, potentially attracting further investment and collaboration.
